Jasper Therapeutics(JSPRW)
Focus: Jasper Therapeutics is a publicly-traded biotechnology company focused on humanized monoclonal antibodies across oncology, dermatology, respiratory, and ophthalmology indications. The company is in early clinical stages with a pre-revenue model and limited near-term commercialization catalysts.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Jasper Therapeutics?
AI assessmentEarly-stage biotech with meaningful execution risk; suitable only for risk-tolerant scientists seeking deep research roles, not career stability.
Why Work Here
- Public company status provides liquidity and transparency versus private biotech peers
- Focused pipeline in oncology and dermatology with potential for differentiated mAb therapies
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Re-resection
GlioblastomaClinician and Non-clinician staff training
LGBT HealthClinical Trials (1)
Help build intelligence for Jasper Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.